Cardiovascular diseases (CVDs) are the leading cause of death, disability and
hospitalization in Italy. Primary prevention strategies are able to prevent clinically evident …

Cardiovascular complications following pneumonia: focus on p... : Current Opinion in Cardiology
Cardiovascular complications following pneumonia: focus on pneumococcus and heart failure …

Hypercholesterolemia is a major risk factor in atherosclerosis development and lipid-
lowering drugs (ie, statins) remain the treatment of choice. Despite effective reduction of LDL …

Background Immunodeficient patients are recommended to receive pneumococcal
vaccination. However, there is limited evidence showing effectiveness of the polysaccharide …

Worldwide, chronic diseases (noncommunicable diseases [NCDs]) cause 41 million (71%)
deaths annually. They are the leading cause of mortality in India, contributing to 60% of total …

Respiratory diseases have been the fourth most common cause of death in Poland in recent
year s. Respiratory infection, especially pneumonia, can lead to exacerbation of chronic …

Pneumococcal infections remain a common global cause of significant morbidity and
mortality. The first recommendations for adult pneumococcal vaccination, published in South …

Background and aims Antibodies to phosphocholine and oxidized LDL (oxLDL) are
proposed to modify progression of atherosclerosis. We investigated the prognostic value of …

Background The 23-valent pneumococcal polysaccharide vaccine (PPSV23) ensures
favorable outcomes and reduces the risk of cardiac events in patients on dialysis. However …

Objective To describe the burden of pneumococcal disease and associated risk factors in
the Canadian adult population, delineate available pneumococcal vaccines and associated …